AVNS logo

Avanos Medical (AVNS)

Profile

Full Name

Avanos Medical, Inc.

Ticker Symbol

AVNS

Exchange

NYSE

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

October 21, 2014

Indexes

Not included

Website

http://avanos.com

Employees

2227

Key Details

Price

$12.03(-3.06%)

Market cap

$553.42M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$687.80M(+2.15% YoY)

Annual EPS

-$8.53(-546.21% YoY)

PE ratio

-

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$12.03
AVNS price is $12.03

30-Day Relative Volume

0.72
AVNS 30-day relative volume is 0.72

Price Performance

Price Most recent change

-3.06%
AVNS price was down -3.06% on Apr 15, 2025

Price YTD change

-24.43%
AVNS price is down -24.43% since January 1st

Price 1-year change

-35.5%
AVNS price is down -35.5% year-on-year

Price 3-year change

-62.32%
AVNS price is down -62.32% over the past 3 years

Price Range

Price All-time high

$72.96
AVNS price is currently -83.51% below its historical high of $72.96

Price 3-year low

$11.91
AVNS price is currently +1.01% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$553.42M
AVNS market capitalization is $553.42 million

Market cap 3-year change

-63.38%
AVNS market capitalization is down -63.38% over the past 3 years

Market cap All-time high

$3.44B
AVNS market capitalization is currently -83.89% below its historical high of $3.44 billion

Market cap sector rank

70.48%
AVNS market capitalization is higher than 70.48% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-0.14%
AVNS shares outstanding is down -0.14% year-on-year

Shares Outstanding 3-Year Change

-2.79%
AVNS shares outstanding is down -2.79% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.69
AVNS beta is 0.69

200-day SMA

$19.15
AVNS price is currently -37.18% below its 200-day simple moving average

50-day SMA

$14.85
AVNS price is currently -18.97% below its 50-day simple moving average

RSI

27.93
AVNS 14-day relative strength index is 27.93

Volume

0.72
AVNS 30-day relative volume is 0.72

ATR

$0.59
AVNS average true range is $0.59

10-day Historical Volatility

57.16%
AVNS 10-day historical volatility is 57.16%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$687.80M
AVNS annual revenue is $687.80 million

Revenue Analysts estimate

$673.50M
AVNS annual revenue is currently +2.12% higher than the consensus analysts' forecast

Revenue 1-year change

+2.15%
AVNS annual revenue is up +2.15% year-on-year

Revenue Sector rank

77.21%
AVNS annual revenue is higher than 77.21% of companies in Healthcare sector

EPS

EPS

-$8.53
AVNS annual earnings per share is -$8.53

EPS Analysts estimate

$1.13
AVNS annual earnings per share is currently -858.22% lower than the consensus analysts' forecast

EPS 1-year change

-546.21%
AVNS annual earnings per share is down -546.21% year-on-year

EPS Sector rank

13.09%
AVNS annual earnings per share is higher than 13.09% of companies in Healthcare sector

Profit

Gross profit

$381.30M
AVNS annual gross profit is $381.30 million

Gross margin

55.44%
AVNS annual gross profit margin is 55.44%

Operating profit

$40.50M
AVNS annual operating income is $40.50 million

Operating margin

5.89%
AVNS annual operating profit margin is 5.89%

Net income

-$392.10M
AVNS annual net profit is -$392.10 million

Net margin

-57.01%
AVNS annual net profit margin is -57.01%

Expenses

Total expenses

$647.30M
AVNS annual total expenses is $647.30 million

Operating expenses

$340.80M
AVNS annual total operating expenses is $340.80 million

Cost of goods sold

$306.50M
AVNS annual cost of goods sold is $306.50 million

Selling, general & administrative expenses

$318.50M
AVNS annual SGA is $318.50 million

Depreciation and amortization

$45.50M
AVNS annual depreciation & amortization is $45.50 million

Interest expense

$12.20M
AVNS annual interest expense is $12.20 million

Income tax

-$17.00M
AVNS annual income tax is -$17.00 million

EBIT & EBITDA

EBIT

-$391.10M
AVNS annual earnings before interest & taxes is -$391.10 million

EBITDA

-$345.60M
AVNS annual EBITDA is -$345.60 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.15B
AVNS annual total assets is $1.15 billion

Non current assets

$760.80M
AVNS annual long term assets is $760.80 million

Current assets

$393.40M
AVNS annual total current assets is $393.40 million

Cash and cash equivalents

$107.70M
AVNS annual cash & cash equivalents is $107.70 million

Accounts receivable

$127.90M
AVNS annual accounts receivable is $127.90 million

Inventory

$138.80M
AVNS annual inventory is $138.80 million

Liabilities

Total liabilities

$325.70M
AVNS annual total liabilities is $325.70 million

Long term liabilities

$159.80M
AVNS annual total long term liabilities is $159.80 million

Current liabilities

$165.90M
AVNS annual total current liabilities is $165.90 million

Accounts payable

$54.30M
AVNS annual accounts payable is $54.30 million

Debt

Total debt

$170.20M
AVNS annual total debt is $170.20 million

Total debt 1-year change

-18.6%
AVNS annual total debt is down -18.6% year-on-year

Long term debt

$149.90M
AVNS annual long term debt is $149.90 million

Short term debt

$20.30M
AVNS annual short term debt is $20.30 million

Equity & Capital

Shareholders equity

$828.50M
AVNS annual stockholders equity is $828.50 million

Book value

$828.50M
AVNS annual book value is $828.50 million

Retained earnings

-$707.00M
AVNS annual retained earnings is -$707.00 million

Working capital

$227.50M
AVNS annual working capital is $227.50 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$100.70M
AVNS annual cash flow from operations is $100.70 million

Cash from operations 1-year change

+210.8%
AVNS annual cash flow from operations is up +210.8% year-on-year

Cash from investing

-$27.50M
AVNS annual cash flow from investing activities is -$27.50 million

Cash from investing 1-year change

-227.31%
AVNS annual cash flow from investing activities is down -227.31% year-on-year

Cash from financing

-$49.10M
AVNS annual cash flow from financing activities is -$49.10 million

Cash from financing 1-year change

+47.88%
AVNS annual cash flow from financing activities is up +47.88% year-on-year

CAPEX

CAPEX

$17.80M
AVNS annual capital expenditures is $17.80 million

CAPEX 1-year change

0%
AVNS {parameterFullLabel} has remained unchanged year-on-year

Free Cash Flow

Free cash flow

$82.90M
AVNS annual free cash flow is $82.90 million

Free cash flow 1-year change

+467.81%
AVNS annual free cash flow is up +467.81% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

55.44%
AVNS annual gross profit margin is 55.44%

Operating margin

5.89%
AVNS annual operating profit margin is 5.89%

Net margin

-57.01%
AVNS annual net profit margin is -57.01%

ROA & ROE

ROA

-27.55%
AVNS annual return on assets is -27.55%

ROE

-37.98%
AVNS annual return on equity is -37.98%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
AVNS price to earnings ratio value is unknown

PE ratio Sector rank

-
AVNS price to earnings ratio is unknown

PB Ratio

PB ratio

0.67
AVNS price to book ratio is 0.67

PB ratio Sector rank

35.23%
AVNS price to book ratio is higher than 35.23% of companies in Healthcare sector

PS Ratio

PS ratio

0.80
AVNS price to sales ratio is 0.80

PS ratio Sector rank

24.36%
AVNS price to sales ratio is higher than 24.36% of companies in Healthcare sector

Enterprise value

Enterprise value

$615.92M
AVNS enterprise value is $615.92 million

Enterprise value Sector rank

71.13%
AVNS enterprise value is higher than 71.13% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.78
AVNS EV/EBITDA is -1.78

EV/EBITDA Sector rank

33.77%
AVNS EV/EBITDA is higher than 33.77% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.37
AVNS annual current ratio is 2.37

Quick ratio

1.53
AVNS annual quick ratio is 1.53

Leverage

Debt to equity

0.16
AVNS annual debt to equity ratio is 0.16

Interest coverage ratio

-32.06
AVNS annual interest coverage ratio is -32.06

Risk & Stability

Piotroski F-Score

6
AVNS piotroski f-score is 6

Altman Z-Score

-0.12
AVNS altman z-score is -0.12

Analyst ratings

Recent major analysts updates

May 7, 24 JMP Securities
Market Perform
Jul 25, 23 Keybanc
Sector Weight
Jun 21, 23 Stifel
Hold
May 22, 23 CL King
Buy
May 4, 23 Morgan Stanley
Underweight
Feb 22, 23 Morgan Stanley
Underweight
Jan 6, 23 Morgan Stanley
Underweight
Nov 3, 22 Keybanc
Overweight
Oct 11, 22 Morgan Stanley
Underweight
Aug 10, 22 Keybanc
Overweight

Institutional Ownership

Similar stocks

SIBN logo
SI-BONE (SIBN)
COGT logo
Cogent Biosciences (COGT)
ANAB logo
AnaptysBio (ANAB)
GHRS logo
GH Research (GHRS)
PHAR logo
Pharming Group NV (PHAR)
ORGO logo
Organogenesis Holdings (ORGO)
BCYC logo
Bicycle Therapeutics (BCYC)
VALN logo
Valneva SE (VALN)
ACCD logo
Accolade (ACCD)
  • What is the ticker symbol for Avanos Medical?
  • Does Avanos Medical pay dividends?
  • What sector is Avanos Medical in?
  • What industry is Avanos Medical in?
  • What country is Avanos Medical based in?
  • When did Avanos Medical go public?
  • Is Avanos Medical in the S&P 500?
  • Is Avanos Medical in the NASDAQ 100?
  • Is Avanos Medical in the Dow Jones?
  • When was Avanos Medical's last earnings report?
  • When does Avanos Medical report earnings?
  • Should I buy Avanos Medical stock now?

What is the ticker symbol for Avanos Medical?

The ticker symbol for Avanos Medical is NYSE:AVNS

Does Avanos Medical pay dividends?

No, Avanos Medical does not pay dividends

What sector is Avanos Medical in?

Avanos Medical is in the Healthcare sector

What industry is Avanos Medical in?

Avanos Medical is in the Medical Devices industry

What country is Avanos Medical based in?

Avanos Medical is headquartered in United States

When did Avanos Medical go public?

Avanos Medical's initial public offering (IPO) was on October 21, 2014

Is Avanos Medical in the S&P 500?

No, Avanos Medical is not included in the S&P 500 index

Is Avanos Medical in the NASDAQ 100?

No, Avanos Medical is not included in the NASDAQ 100 index

Is Avanos Medical in the Dow Jones?

No, Avanos Medical is not included in the Dow Jones index

When was Avanos Medical's last earnings report?

Avanos Medical's most recent earnings report was on Feb 26, 2025

When does Avanos Medical report earnings?

The next expected earnings date for Avanos Medical is May 2, 2025

Should I buy Avanos Medical stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page